Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

Clinical trial NCT00322517 · COMPLETED

Trial details

NCT number: NCT00322517
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2006-04-01
Primary completion: 2008-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.